These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17315407)

  • 21. Methods of detoxification and their role in treating patients with opioid dependence.
    O'Connor PG
    JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388
    [No Abstract]   [Full Text] [Related]  

  • 22. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.
    Kleber HD; Topazian M; Gaspari J; Riordan CE; Kosten T
    Am J Drug Alcohol Abuse; 1987; 13(1-2):1-17. PubMed ID: 3687878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid opiate detoxification.
    Bartter T; Gooberman LL
    Am J Drug Alcohol Abuse; 1996 Nov; 22(4):489-95. PubMed ID: 8911587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
    Sigmon SC; Bisaga A; Nunes EV; O'Connor PG; Kosten T; Woody G
    Am J Drug Alcohol Abuse; 2012 May; 38(3):187-99. PubMed ID: 22404717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.
    Sibai M; Mishlen K; Nunes EV; Levin FR; Mariani JJ; Bisaga A
    Am J Drug Alcohol Abuse; 2020 May; 46(3):289-296. PubMed ID: 31860366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
    Pozzi G; Conte G; De Risio S
    Drug Alcohol Depend; 2000 Jun; 59(3):287-94. PubMed ID: 10812288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD002021. PubMed ID: 19821290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutical potentialities of rapid opioid detoxification].
    Sivolap IuP
    Anesteziol Reanimatol; 2002; (6):55-8. PubMed ID: 12611160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
    Ziedonis DM; Amass L; Steinberg M; Woody G; Krejci J; Annon JJ; Cohen AJ; Waite-O'Brien N; Stine SM; McCarty D; Reid MS; Brown LS; Maslansky R; Winhusen T; Babcock D; Brigham G; Muir J; Orr D; Buchan BJ; Horton T; Ling W
    Drug Alcohol Depend; 2009 Jan; 99(1-3):28-36. PubMed ID: 18805656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with clonidine-naltrexone for rapid opiate detoxification.
    Senft RA
    J Subst Abuse Treat; 1991; 8(4):257-9. PubMed ID: 1787550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002021. PubMed ID: 16437438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
    Digiusto E; Lintzeris N; Breen C; Kimber J; Mattick RP; Bell J; Ali R; Saunders JB;
    Addict Behav; 2005 Mar; 30(3):443-56. PubMed ID: 15718062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade.
    Galloway G; Hayner G
    J Psychoactive Drugs; 1993; 25(3):251-2. PubMed ID: 8258763
    [No Abstract]   [Full Text] [Related]  

  • 38. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique.
    Brewer C; Rezae H; Bailey C
    Br J Psychiatry; 1988 Sep; 153():340-3. PubMed ID: 3250670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.